Did you know that every minute, a child goes blind? Or that 80 percent of global blindness is preventable? This October 13 is World Sight Day, a day established to shed light on the impact of blindness and to raise awareness around the steps we can take to prevent it.

This past summer, I had the incredible privilege of interning with the Resource Development team at the Sabin Vaccine Institute. As someone who is passionate about global health equity, I was excited to learn more about what it means to work at non-profit within the global health field. Looking back on my experience, I am so thankful that I had the opportunity at work at Sabin and support its mission to alleviate needless human suffering from vaccine preventable and neglected tropical diseases.
During my many years as a diplomat, I saw firsthand how the power of collective action can be extraordinarily important in shaping momentous changes. A few examples include: the creation of the PEPFAR program to combat HIV/AIDS, the accelerated response to terrorism following the East African embassy bombings, effective international coordination to tackle the SARS and avian flu threats, and the constructive collaboration between the United States and Vietnam on the issue of Agent Orange.

Last year, the leaders of some of the wealthiest nations pledged help control and eliminate the most common neglected tropical diseases (NTDs) by 2020.

Photo: Sabin CEO Michael W. Marine, Ambassador (Ret.), with Former President of Ghana, John Kufuor

Sabin President Peter Hotez Testifies at House Hearings on Zika, Infectious Diseases

Peter Hotez, M.D., Ph.D., president of Sabin, testified this week at two congressional hearings: the House Energy and Commerce Subcommittee on Oversight and Investigations hearing, “Examining the U.S. Public Health Response to the Zika Virus”; and the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations on “The Growing Threat of Cholera and Other Diseases in the Middle East.”

Kenneth Kelley and Jordan Orange Join Sabin Vaccine Institute Board of Trustees

WASHINGTON, D.C. — January 13, 2016 — The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Kenneth Kelley, M.B.A., and Jordan Orange, M.D., Ph.D., to its Board of Trustees. Mr. Kelley is a Harvard Senior Advanced Leadership Fellow, focusing on global health, biosecurity and the market inefficiency leading to a lack of vaccines against neglected tropical diseases (NTDs) and emerging pandemic threats. Dr. Orange is chief of Immunology, Allergy and Rheumatology, and professor and section head for Immunology, Allergy and Rheumatology in the pediatrics department at Baylor College of Medicine.


Subscribe to RSS - Global Network for NTDS